Copyright
©2014 Baishideng Publishing Group Inc.
World J Hepatol. Sep 27, 2014; 6(9): 626-631
Published online Sep 27, 2014. doi: 10.4254/wjh.v6.i9.626
Published online Sep 27, 2014. doi: 10.4254/wjh.v6.i9.626
Ref. | Country | Year | Study period | Type of LT | Case number | Recurrence - free survival | P | % Recur-rence rate | P | Criteria used | % Outside Milan | Differencein tumorcharact-eristics | Median follow-up period (mo) | ||
1-yr | 3-yr | 5-yr | |||||||||||||
Impaired results in LDLT | |||||||||||||||
Park et al[10] | South Korea | 2014 | 1999-2010 | LDLT | 166 | 89 | 81 | 0.045 | 19 | 0.045 | UCSF | NA | none | 35 | |
DDLT | 50 | 96 | 94 | 6 | |||||||||||
Vakili et al[13] | United States | 2009 | 1999-2007 | LDLT | 28 | 29 | 0.05 | UNOS | 25 | none | 41 | ||||
DDLT | 65 | 12 | |||||||||||||
Kulik et al[12] | United States | 2012 | 1998-2010 | LDLT | 100 | 80 | 66 | 56 | 0.05 | 38 | 0.0004 | UNOS | 59 | More aggressive in LDLT | 60 |
Multi-center | DDLT | 97 | 90 | 81 | 73 | 11 | 30 | ||||||||
Lo et al[14] | Hong Kong | 2007 | 1995-2004 | LDLT | 43 | 93 | 71 | 71 | 0.029 | 29 | 0.029 | UCSF | 26 | More aggressive in LDLT | 33 |
DDLT | 17 | 100 | 100 | 100 | 0 | 29 | |||||||||
Comparable results | |||||||||||||||
Sandhu et al[15] | Canada | 2013 | 1996-2009 | LDLT | 58 | 88 | 75 | 70 | NS | 17 | NS | Toronto criteria | 28 | none | 38 |
DDLT | 287 | 86 | 75 | 70 | 15 | 32 | 31 | ||||||||
Bhangui et al[16] | France | 2011 | 2000-2009 | LDLT | 36 | 100 | 89 | 88 | NS | 13 | NS | UCSF | 27 | none | 58 |
DDLT | 120 | 93 | 89 | 86 | 13 | 21 | 50 | ||||||||
Li et al[36] | China | 2010 | 2005-2009 | LDLT | 38 | 71 | 42 | NS | 50 | NS | UCSF | 79 | none | 25 | |
DDLT | 101 | 76 | 41 | 55 | 68 | ||||||||||
Di Sandro et al[35] | Italy | 2009 | 2000-2007 | LDLT | 25 | 96 | 96 | NS | 4 | NS | Milan | 20 | none | NA | |
DDLT | 154 | 91 | 89 | 11 | 31 | ||||||||||
Sotiropoulos et al[20] | Germany | 2007 | 1998-2006 | LDLT | 45 | 88 | 75 | NS | 12 | NS | UCSF | 44 | none | NA | |
DDLT | 55 | 81 | 14 | ||||||||||||
Hwang et al[8] | South Korea | 2005 | 1992-2002 | LDLT | 237 | 83 | 80 | NS | 18 | NS | 27 | none | 26 | ||
Multi-center | DDLT | 75 | 88 | 82 | 16 | 29 | 45 | ||||||||
Gondolesi et al[17] | United States | 2004 | 1988-2002 | LDLT | 36 | 82 | 74 | NS | 19 | NS | UNOS | 53 | none | 15 | |
DDLT | 165 | 90 | 83 | 19 |
-
Citation: Akamatsu N, Sugawara Y, Kokudo N. Living-donor
vs deceased-donor liver transplantation for patients with hepatocellular carcinoma. World J Hepatol 2014; 6(9): 626-631 - URL: https://www.wjgnet.com/1948-5182/full/v6/i9/626.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i9.626